Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

  • This share is currently suspended. It was suspended at a price of 305.00

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
305.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 137.20 (81.764%)
Market Cap: £180.06m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Trading Update

4 Oct 2019 07:00

RNS Number : 7416O
Treatt PLC
04 October 2019
 

Information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

4 October 2019

 

TREATT PLC

("Treatt" or "the Group")

 

Trading update for year ended 30 September 2019

 

Treatt, the manufacturer and supplier of innovative ingredient solutions for the flavour, fragrance, beverage and consumer product industries today publishes a trading update for the year ended 30 September 2019.

 

The Board is pleased to confirm that, notwithstanding a very significant fall in certain key citrus raw material prices, and some foreign exchange headwinds, the Group has performed well in the second half of the financial year. Consequently, the Board expects to report profit before tax and exceptional items for the year ended 30 September 2019 in line with its expectations.

 

Revenue for the year is expected to be approximately £112.7m, an increase of 1% (or decrease of 2% in constant currency) compared with the prior year. As reported in May 2019, revenue for the year has been impacted by a substantial fall in citrus raw material input prices, with orange oil (which represents approximately 33% of Group revenue) prices falling by more than 50% over the year and lemon oil prices also seeing substantial price weakness.

 

Although reported revenue from our citrus category (representing 54% of Group revenue) fell by 10%, our strategy to diversify our portfolio of natural ingredient solutions delivered a very encouraging 16% growth in non-citrus revenues: tea was up 42%, health & wellness (including sugar reduction) grew by 23% and fruit & vegetables grew by 35% as the Group's clean label innovations continue to perform well in the market place. Whilst 'natural' now represents approximately 81% of the Group's portfolio, we also saw healthy growth of 16% in the synthetic flavour and fragrance market.

 

During the 2019 financial year the Group made significant progress with its two principal strategic investment projects being the expansion of our US facility and the relocation of our UK facility. We successfully completed the further development of our US facility, doubling the capacity in our non-citrus natural tea, health & wellness and fruit & vegetable categories as well as quadrupling the size of our US technical and innovation centre as we invest more in R&D to drive further product innovation. In addition, and as we reported last month, the main contractors have begun work on our new UK facility which we expect to transition across to in the latter half of 2020.

 

There was a net improvement in working capital with lower inventories and a reduction in trade debtors contributing to a strong cash performance during the financial year. The Group ended the year with a net cash balance of £15.8m, being a net inflow for the year of £5.8m.

 

As we begin our new financial year, the impact of lower citrus raw material prices is likely to continue to affect our citrus business, whilst we expect the momentum in our non-citrus categories to continue and innovations in cold brew coffee, a new market for Treatt, to gain traction. As new capacity at our US facility comes on stream the business will begin to see the benefits from this investment and, as we look forward to moving into our new UK facility later next year, the Board enters the year ahead with confidence.

 

Treatt's results for the year ended 30 September 2019 will be announced on 26 November 2019.

 

 

 

Enquiries:

 

Treatt plc +44 (0)1284 702500

Daemmon Reeve Chief Executive Officer

Richard Hope Chief Financial Officer

 

Broker

Investec Bank Plc

Patrick Robb +44 (0)20 7597 5970

David Anderson

Alex Wright

 

Public relations

DRD Partnership

Lawrence Dore +44 (0)20 3951 0349

 

 

About the Group

Treatt is a global, independent supplier of innovative ingredient solutions for the flavour, fragrance and multinational consumer product industries, particularly in the beverage sector. Renowned for its technical expertise and knowledge of ingredients, their origins and market conditions, Treatt is recognised as a leader in its field.

 

The Group employs over 300 staff in Europe, North America, Africa and Asia and has manufacturing facilities in the UK, USA and Kenya. Its international footprint enables the Group to deliver powerful and integrated solutions for the food, beverage and fragrance industries across the globe.

 

For further information about the Group, visit www.treatt.com.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS

This announcement contains forward-looking statements that are subject to risk factors associated with, among other things, the economic and business circumstances occurring from time to time in the countries, sectors and markets in which the Group operates. It is believed that the expectations reflected in these statements are reasonable but they may be affected by a wide range of variables which could cause actual results to differ materially from those currently anticipated. No assurances can be given that the forward-looking statements in this announcement will be realised. The forward-looking statements reflect the knowledge and information available at the date of preparation of this announcement and the Group undertakes no obligation to update these forward-looking statements. Nothing in this announcement should be construed as a profit forecast.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFSRIALVIIA
Date   Source Headline
29th Nov 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20227:10 amRNSFull Year Results
10th Nov 20227:00 amRNSNotice of Results
9th Nov 20228:50 amRNSChange of Company Secretary and Director’s Duties
1st Nov 20224:26 pmRNSDirectorate Change - Replacement
1st Nov 202210:05 amRNSBoard Change
17th Oct 20222:36 pmRNSHoling(s) in Company
17th Oct 20222:36 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSTrading Update
16th Sep 20222:28 pmRNSBoard Committee Changes
1st Sep 202210:39 amRNSNotification of Transaction of a Director
31st Aug 20222:37 pmRNSNotification of Transactions of Director
16th Aug 202211:33 amRNSNotification of Transactions of Director
16th Aug 202211:30 amRNSNotification of Transactions of Director
15th Aug 202211:40 amRNSNotification of Transactions of Director
15th Aug 202211:37 amRNSNotification of Transactions of Director
15th Aug 20227:00 amRNSTrading Update
9th Aug 20223:25 pmRNSHolding(s) in Company
14th Jul 20226:23 pmRNSNotification of Transactions of Director
11th Jul 20227:00 amEQSTreatt (TET): New facility to drive growth
24th Jun 20221:15 pmRNSChairman Succession and Board Change
23rd Jun 202210:04 amRNSDirector Declaration
22nd Jun 20227:00 amRNSVoting Rights and Capital
21st Jun 20222:43 pmRNSHolding(s) in Company
20th Jun 20225:25 pmRNSNotification of Transactions of Director
20th Jun 20225:22 pmRNSNotification of Transactions of Director
8th Jun 20224:50 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
1st Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st May 20222:54 pmRNSHolding(s) in Company
27th May 20227:00 amRNSCapital Markets Day
19th May 20225:03 pmRNSHolding(s) in Company
17th May 202211:50 amRNSHolding(s) in Company
13th May 20224:37 pmRNSHolding(s) in Company
13th May 20224:37 pmRNSNotification of Transactions of Director
12th May 20226:17 pmRNSHolding(s) in Company
12th May 20225:07 pmRNSHolding(s) in Company
12th May 202212:09 pmRNSNotification of Transactions of Director
11th May 20224:24 pmRNSHolding(s) in Company
11th May 20223:18 pmRNSNotification of Transactions of Director
10th May 20227:00 amRNSHalf-year Report
27th Apr 202210:28 amRNSDirector Declaration
11th Apr 20227:00 amRNSHalf Year Trading Update and Notice of Results
1st Apr 20221:59 pmRNSVoting Rights and Capital
30th Mar 20223:00 pmRNSNotification of Transactions of Director
24th Mar 20225:02 pmRNSNotification of Transactions of a PCA
22nd Mar 20224:55 pmRNSNotification of Transactions of Directors & PCA
22nd Mar 20229:10 amRNSDirector Declaration
8th Mar 202211:09 amRNSStandard Form for notification of major holdings
7th Mar 20222:19 pmRNSNotifications of Transactions of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.